Related Experiment Video
Updated: Jun 23, 2026
10:21
Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Cardiac troponin T and familial hypertrophic cardiomyopathy: an energetic affair
Ketty Schwartz1, Jean-Jacques Mercadier
1Institut National de la Santé et de la Recherche Médicale ( INSERM) U582, Institut de Myologie, Groupe Hospitalier Pitié-Salpêtrière, Paris, France. k.schwartz@myologie.chups.jussieu.fr.
The Journal of Clinical Investigation
|September 4, 2003
Summary
Familial hypertrophic cardiomyopathy from cardiac troponin T mutations may not cause significant hypertrophy. A new study reveals a cTnT mutation disrupts energy metabolism, leading to cardiomyopathy.
Area of Science:
- Biochemistry
- Cardiology
- Genetics
Background:
- Familial hypertrophic cardiomyopathy (HCM) linked to cardiac troponin T (cTnT) mutations typically presents with sudden cardiac death.
- Patients with these mutations often lack significant ventricular hypertrophy, suggesting mechanisms beyond altered myocardial contractility.
Discussion:
- A specific missense mutation in cTnT was investigated for its role in HCM pathogenesis.
- The study explored cellular mechanisms underlying HCM in the absence of pronounced hypertrophy.
Key Insights:
- A single missense mutation in cardiac troponin T (cTnT) profoundly disrupts cellular energy metabolism.
- This disruption in energy metabolism is identified as a key driver of cardiomyopathy in affected patients.
Outlook:
- Further research into the precise metabolic pathways affected by cTnT mutations is warranted.
- Understanding these mechanisms could lead to novel therapeutic strategies for HCM.
Related Concept Videos
01:27Specialized Characteristics of Cardiac Muscles
The primary role of cardiac muscles is to propel blood throughout the cardiovascular system. The cardiac muscle cells, or cardiomyocytes, exhibit specialized characteristics that allow them to perform this function.
Cardiac muscle cells are smaller than skeletal muscles, averaging 10–20 mm in diameter and 50–100 mm in length. However, they have large energy demands for continuous contraction and relaxation. This energy is almost exclusively derived from aerobic metabolism of energy reserves in...
Cardiac muscle cells are smaller than skeletal muscles, averaging 10–20 mm in diameter and 50–100 mm in length. However, they have large energy demands for continuous contraction and relaxation. This energy is almost exclusively derived from aerobic metabolism of energy reserves in...
01:29Pathophysiology of Cardiac Performance
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
01:25Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...